A krónikus vírushepatitisek hazai ellátási rendszerének sajátosságai: Hepatitis Regiszter és a Prioritási Index

Mihály Makara, Gábor Horváth, F. Szalay, István Tornai, B. Hunyady

Research output: Article

8 Citations (Scopus)

Abstract

Hepatitis Registry was developed by the Hepatology Section of the Hungarian Gastroenterology Society with the contribution of the Foundation for Liver Patients. The main task was to register all interferon based treatments of chronic hepatitis C and B and to facilitate the preauthorization process. The registry helped to clarify the number and characteristics of hepatitis C patients waiting for triple therapy; 3000 previously failed patients are still eligible for protease inhibitor therapy, 40% of them already developed cirrhosis stage and 40% are null responders to the previous therapy. As a file is created for treatment authorization, the system counts automatically the Priority Index according to the calculation set in the guideline. Priority Index reflects the urgency of treatment. The most prominent parameter of the Index is the degree of fibrosis, but it also takes into account the progression rate, prognostic factors, and special situations. Orv. Hetil., 2013, 154, 1151-1155.

Original languageHungarian
Pages (from-to)1151-1155
Number of pages5
JournalOrvosi Hetilap
Volume154
Issue number29
DOIs
Publication statusPublished - júl. 1 2013

Fingerprint

Hungary
Chronic Hepatitis
Hepatitis
Registries
Organizations
Gastroenterology
Fibrosis
Therapeutics
Chronic Hepatitis B
Chronic Hepatitis C
Hepatitis C
Protease Inhibitors
Interferons
Guidelines
Liver

Keywords

  • boceprevir
  • cirrhosis
  • direct acting antiviral agents
  • direkt ható antivirális szerek
  • hepatitis C
  • hepatitis C virus
  • kezelési prioritás
  • priority of treatment
  • registry
  • telaprevir

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A krónikus vírushepatitisek hazai ellátási rendszerének sajátosságai : Hepatitis Regiszter és a Prioritási Index. / Makara, Mihály; Horváth, Gábor; Szalay, F.; Tornai, István; Hunyady, B.

In: Orvosi Hetilap, Vol. 154, No. 29, 01.07.2013, p. 1151-1155.

Research output: Article

@article{7b91cfabd7f34b1b90c572a020468610,
title = "A kr{\'o}nikus v{\'i}rushepatitisek hazai ell{\'a}t{\'a}si rendszer{\'e}nek saj{\'a}toss{\'a}gai: Hepatitis Regiszter {\'e}s a Priorit{\'a}si Index",
abstract = "Hepatitis Registry was developed by the Hepatology Section of the Hungarian Gastroenterology Society with the contribution of the Foundation for Liver Patients. The main task was to register all interferon based treatments of chronic hepatitis C and B and to facilitate the preauthorization process. The registry helped to clarify the number and characteristics of hepatitis C patients waiting for triple therapy; 3000 previously failed patients are still eligible for protease inhibitor therapy, 40{\%} of them already developed cirrhosis stage and 40{\%} are null responders to the previous therapy. As a file is created for treatment authorization, the system counts automatically the Priority Index according to the calculation set in the guideline. Priority Index reflects the urgency of treatment. The most prominent parameter of the Index is the degree of fibrosis, but it also takes into account the progression rate, prognostic factors, and special situations. Orv. Hetil., 2013, 154, 1151-1155.",
keywords = "boceprevir, cirrhosis, direct acting antiviral agents, direkt hat{\'o} antivir{\'a}lis szerek, hepatitis C, hepatitis C virus, kezel{\'e}si priorit{\'a}s, priority of treatment, registry, telaprevir",
author = "Mih{\'a}ly Makara and G{\'a}bor Horv{\'a}th and F. Szalay and Istv{\'a}n Tornai and B. Hunyady",
year = "2013",
month = "7",
day = "1",
doi = "10.1556/OH.2013.29671",
language = "Hungarian",
volume = "154",
pages = "1151--1155",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "29",

}

TY - JOUR

T1 - A krónikus vírushepatitisek hazai ellátási rendszerének sajátosságai

T2 - Hepatitis Regiszter és a Prioritási Index

AU - Makara, Mihály

AU - Horváth, Gábor

AU - Szalay, F.

AU - Tornai, István

AU - Hunyady, B.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Hepatitis Registry was developed by the Hepatology Section of the Hungarian Gastroenterology Society with the contribution of the Foundation for Liver Patients. The main task was to register all interferon based treatments of chronic hepatitis C and B and to facilitate the preauthorization process. The registry helped to clarify the number and characteristics of hepatitis C patients waiting for triple therapy; 3000 previously failed patients are still eligible for protease inhibitor therapy, 40% of them already developed cirrhosis stage and 40% are null responders to the previous therapy. As a file is created for treatment authorization, the system counts automatically the Priority Index according to the calculation set in the guideline. Priority Index reflects the urgency of treatment. The most prominent parameter of the Index is the degree of fibrosis, but it also takes into account the progression rate, prognostic factors, and special situations. Orv. Hetil., 2013, 154, 1151-1155.

AB - Hepatitis Registry was developed by the Hepatology Section of the Hungarian Gastroenterology Society with the contribution of the Foundation for Liver Patients. The main task was to register all interferon based treatments of chronic hepatitis C and B and to facilitate the preauthorization process. The registry helped to clarify the number and characteristics of hepatitis C patients waiting for triple therapy; 3000 previously failed patients are still eligible for protease inhibitor therapy, 40% of them already developed cirrhosis stage and 40% are null responders to the previous therapy. As a file is created for treatment authorization, the system counts automatically the Priority Index according to the calculation set in the guideline. Priority Index reflects the urgency of treatment. The most prominent parameter of the Index is the degree of fibrosis, but it also takes into account the progression rate, prognostic factors, and special situations. Orv. Hetil., 2013, 154, 1151-1155.

KW - boceprevir

KW - cirrhosis

KW - direct acting antiviral agents

KW - direkt ható antivirális szerek

KW - hepatitis C

KW - hepatitis C virus

KW - kezelési prioritás

KW - priority of treatment

KW - registry

KW - telaprevir

UR - http://www.scopus.com/inward/record.url?scp=84880438009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880438009&partnerID=8YFLogxK

U2 - 10.1556/OH.2013.29671

DO - 10.1556/OH.2013.29671

M3 - Article

C2 - 23853348

AN - SCOPUS:84880438009

VL - 154

SP - 1151

EP - 1155

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 29

ER -